GILEAD SCIENCES, INC. - Common Stock (GILD)

Historical Holders from Q1 2014 to Q3 2025

Symbol
GILD on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
1.24B
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1.05B
Holdings value
$117B
% of all portfolios
0.052%
Grand Portfolio weight change
-0.004%
Number of holders
1989
Number of buys
965
Number of sells
-836
Average Value change %
0%
Average buys %
+0.006%
Average sells %
-0.008%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GILEAD SCIENCES, INC. - Common Stock (GILD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.2% $10.8B 102M BlackRock, Inc. 31 Mar 2025
Capital World Investors 4.3% $5.71B 53.8M Capital World Investors 31 Mar 2025

Institutional Holders of GILEAD SCIENCES, INC. - Common Stock (GILD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.05B $117B -$2.27B $111.00 1,989
2025 Q2 1.07B $119B +$3.51B $110.87 2,000
2025 Q1 1.04B $117B -$1.85B $112.05 1,991
2024 Q4 1.06B $98B +$1.6B $92.37 1,868
2024 Q3 1.04B $87.3B +$497M $83.84 1,702
2024 Q2 1.03B $70.8B -$264M $68.61 1,666
2024 Q1 1.04B $76.1B -$499M $73.25 1,705
2023 Q4 1.04B $84.7B +$255M $81.01 1,763
2023 Q3 1.04B $78B -$75.6M $74.94 1,671
2023 Q2 1.04B $80.4B +$427M $77.07 1,687
2023 Q1 1.03B $85.8B +$629M $82.97 1,717
2022 Q4 1.03B $88.6B +$2.22B $85.85 1,747
2022 Q3 1B $62B +$690M $61.69 1,570
2022 Q2 993M $61.4B +$325M $61.81 1,587
2022 Q1 989M $58.8B -$958M $59.45 1,567
2021 Q4 1.01B $73.3B +$193M $72.61 1,663
2021 Q3 999M $69.8B +$692M $69.85 1,544
2021 Q2 989M $68.1B +$648M $68.86 1,524
2021 Q1 982M $63.4B +$771M $64.63 1,551
2020 Q4 971M $56.5B -$194M $58.26 1,543
2020 Q3 975M $61.6B -$1.22B $63.19 1,524
2020 Q2 990M $76.1B -$471M $76.94 1,618
2020 Q1 998M $74.6B -$1.15B $74.76 1,633
2019 Q4 1.01B $65.9B +$31.7M $64.98 1,547
2019 Q3 1.01B $64.2B -$202M $63.38 1,452
2019 Q2 1.02B $68.7B +$1.16B $67.56 1,472
2019 Q1 1.02B $66B -$244M $65.01 1,476
2018 Q4 1.02B $63.7B +$29.4M $62.55 1,478
2018 Q3 1.02B $78.9B +$2.22B $77.21 1,520
2018 Q2 993M $70.3B -$2.36B $70.84 1,516
2018 Q1 1.02B $77.2B +$357M $75.39 1,558
2017 Q4 1.02B $73.2B +$1.02B $71.64 1,574
2017 Q3 1B $81.4B +$2.31B $81.02 1,501
2017 Q2 978M $69.2B +$314M $70.78 1,514
2017 Q1 975M $66.2B +$5.35B $67.92 1,515
2016 Q4 991M $71B -$497M $71.61 1,565
2016 Q3 995M $78.6B -$3.55B $79.12 1,547
2016 Q2 1.04B $86.7B -$2.51B $83.42 1,587
2016 Q1 1.07B $98.1B -$6.52B $91.86 1,617
2015 Q4 1.14B $115B -$3.13B $101.19 1,621
2015 Q3 1.16B $114B -$3.45B $98.19 1,561
2015 Q2 1.2B $140B -$4.01B $117.08 1,549
2015 Q1 1.23B $121B -$2.15B $98.13 1,481
2014 Q4 1.26B $119B -$4.39B $94.26 1,426
2014 Q3 1.29B $138B -$9.5B $106.45 1,315
2014 Q2 1.38B $114B -$1.97B $82.91 1,253
2014 Q1 1.41B $99.6B -$881M $70.86 1,177